Bal Pharma

{
  "main_header": {
    "sid": 555664,
    "name": "Bal Pharma",
    "stock_name": "Bal Pharma",
    "full_name": "Bal Pharma Ltd",
    "name_url": "stocks-analysis/bal-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "79.88",
    "chg": 1.59,
    "chgp": "2.03%",
    "dir": 1,
    "prev_price": "78.29",
    "mcapval": "127.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524824,
    "symbol": "BALPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE083D01012",
    "curr_date": "May 20",
    "curr_time": "",
    "bse_nse_vol": "35.92 k",
    "exc_status": "Active",
    "traded_date": "May 20, 2026",
    "traded_date_str": "2026 05 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bal-pharma-555664-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Bal Pharma Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-bal-pharma-ltd-3999679",
        "imagepath": "",
        "date": "2026-05-19 23:17:37",
        "description": "The next results date for Bal Pharma Ltd is scheduled for 27 May 2026...."
      },
      {
        "title": "Bal Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-strong-sell-3983925",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BalPharmaLtd_mojoScore_3983925.png",
        "date": "2026-05-10 10:10:37",
        "description": "Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 10 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Bal Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-strong-sell-3967997",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BalPharmaLtd_mojoScore_3967997.png",
        "date": "2026-04-29 10:10:53",
        "description": "Bal Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Bal Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-strong-sell-3951889",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BalPharmaLtd_mojoScore_3951889.png",
        "date": "2026-04-18 10:10:38",
        "description": "Bal Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Bal Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-strong-sell-3934867",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BalPharmaLtd_mojoScore_3934867.png",
        "date": "2026-04-07 10:10:45",
        "description": "Bal Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Markets Rally, But Bal Pharma Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-falls-to-52-week-low-of-rs622-amid-market-downturn-3925565",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BalPharmaLtd_priceRelatedfactors_3925565.png",
        "date": "2026-03-30 15:05:15",
        "description": ""
      },
      {
        "title": "Bal Pharma Ltd Falls to 52-Week Low of Rs 64 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-falls-to-52-week-low-amidst-weak-market-and-fundamental-pressures-3920090",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BalPharmaLtd_priceRelatedfactors_3920090.png",
        "date": "2026-03-27 15:05:10",
        "description": "For the fifth consecutive session, Bal Pharma Ltd closed lower, slipping to a fresh 52-week low of Rs 64 on 27 Mar 2026. This decline comes amid a broader market downturn, but the stock’s underperformance remains pronounced compared to its sector and benchmark indices."
      },
      {
        "title": "Bal Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-strong-sell-3918904",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BalPharmaLtd_mojoScore_3918904.png",
        "date": "2026-03-27 10:10:27",
        "description": "Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 27 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Bal Pharma Ltd Falls to 52-Week Low Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-falls-to-52-week-low-amid-continued-downtrend-3897007",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BalPharmaLtd_priceRelatedfactors_3897007.png",
        "date": "2026-03-17 16:01:09",
        "description": "Bal Pharma Ltd’s shares have declined to within 3.03% of their 52-week low, marking a significant downturn for the micro-cap pharmaceutical company. The stock closed near Rs 66, approaching its lowest price point of Rs 64 over the past year, reflecting ongoing pressures in its market performance and fundamentals."
      }
    ],
    "total": 137,
    "sid": "555664",
    "stock_news_url": "https://www.marketsmojo.com/news/bal-pharma-555664"
  },
  "announcements": [
    {
      "details": "Bal Pharma Limited has informed the Exchange regarding Disclosure of Related Party Transaction disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Bal Pharma Limited - Other General Purpose",
      "datetime": "28-Nov-2019"
    },
    {
      "details": "Bal Pharma Limited Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Bal Pharma Limited - Clarification - Financial Results",
      "datetime": "26-Nov-2019"
    },
    {
      "details": "Bal Pharma Limited has informed the Exchange regarding 'News Paper Publication's of Unaudited financial results for the quarter and half year ended 30/09/2019.'.",
      "source": "NSE",
      "caption": "Bal Pharma Limited - Updates",
      "datetime": "18-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "27 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bal Pharma Ltd has declared <strong>12%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

When is the next results date for Bal Pharma Ltd?

2026-05-19 23:17:37

The next results date for Bal Pharma Ltd is scheduled for 27 May 2026....

Read full news article

Bal Pharma Ltd is Rated Strong Sell

2026-05-10 10:10:37

Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 10 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Bal Pharma Ltd is Rated Strong Sell

2026-04-29 10:10:53

Bal Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Bal Pharma Ltd is Rated Strong Sell

2026-04-18 10:10:38

Bal Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Bal Pharma Ltd is Rated Strong Sell

2026-04-07 10:10:45

Bal Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Markets Rally, But Bal Pharma Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-30 15:05:15

Read full news article

Bal Pharma Ltd Falls to 52-Week Low of Rs 64 as Sell-Off Deepens

2026-03-27 15:05:10

For the fifth consecutive session, Bal Pharma Ltd closed lower, slipping to a fresh 52-week low of Rs 64 on 27 Mar 2026. This decline comes amid a broader market downturn, but the stock’s underperformance remains pronounced compared to its sector and benchmark indices.

Read full news article

Bal Pharma Ltd is Rated Strong Sell

2026-03-27 10:10:27

Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 27 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Bal Pharma Ltd Falls to 52-Week Low Amid Continued Downtrend

2026-03-17 16:01:09

Bal Pharma Ltd’s shares have declined to within 3.03% of their 52-week low, marking a significant downturn for the micro-cap pharmaceutical company. The stock closed near Rs 66, approaching its lowest price point of Rs 64 over the past year, reflecting ongoing pressures in its market performance and fundamentals.

Read full news article

View All News